Dr. Thomas Yorio receives outpouring of praise and admiration

Words of admiration for a distinguished scientist whose career has spanned four decades filled Luibel Hall as faculty, staff and students honored Thomas Yorio, PhD, recipient of the prestigious Barany Prize.

Dr. Yorio, Provost, Executive Vice President for Academic Affairs and Professor of Pharmacology & Neuroscience, will receive the award from the International Society for Eye Research in July.

At the recognition ceremony, UNT Health Science Center President Dr. Michael Williams, DO, MD, MBA,  honored Dr. Yorio for his outstanding accomplishments and the many contributions to research he has made over his career.

"Congratulations on receiving this great award," he said in a pre-recorded video. "We are so proud of you."

The Ernest H. Barany Prize is given every two years in recognition of a scientist’s contributions to research that have increased the understanding of ocular pharmacology directly related or applicable to glaucoma, diabetic retinopathy, macular degeneration or related retinal diseases.

"This is indeed a distinction," said Meharvan "Sonny" Singh, PhD, Dean of the Graduate School of Biomedical Sciences.

Abe Clark, PhD, Professor of Cell Biology and Immunology and Director of the North Texas Eye Research Institute, also spoke of Dr. Yorio’s many contributions to the advancement of eye research, saying, "What a great honor for him to be recognized."

After thanking the audience for the outpouring of well wishes, Dr. Yorio expressed his gratitude to the many people, including his wife, who have supported his work over the years. He ended by presenting the same lecture on corticosteroids and glaucoma that he will deliver at the XXI Biennial Meeting of the International Society for Eye Research.

"Science is a complex series of puzzles, and our job is trying to put the right pieces together," he said. "Thank you to those who help me solve the puzzles – students, postdocs, technicians and faculty."

Recent News

One pill kills graphic
  • On Campus
|Oct 2, 2023

HSC launches One Pill Kills Campaign to combat fentanyl

A synthetic opioid that’s considered exponentially more addictive than heroin, fentanyl is now the leading cause of death for Americans ages 18 to 49. It can be fatal to ingest even a tiny amount, so small it could fit on a pencil eraser. In the face of the deadliest epidemic in the history o...
Clearfield
  • Our People
|Sep 29, 2023

Dr. Michael Clearfield the inaugural winner of the Beyer, Everett, and Luibel Memorial Medal

For more than two decades, Dr. Michael B. Clearfield, DO, MACOI, FACP, has developed the Department of Internal Medicine and Geriatrics at the Texas College of Osteopathic Medicine into one of the largest and most productive academically in the osteopathic profession, serving as the chair from 1982-...
Kari Northeim 2 (002)[66]
  • Our People
|Sep 28, 2023

HSC’s Dr. Kari Northeim and Parker County collaborators awarded SAMHSA grant for rural EMS training and education

Dr. Kari Northeim, School of Public Health assistant professor of population and community health at The University of North Texas Health Science Center at Fort Worth, has been awarded the SAMHSA Rural EMS Training and Education grant in conjunction with HSC community partners, Parker County Hospi...
Graci Finco
  • Research
|Sep 28, 2023

SBS researchers publish innovative study in Nature Scientific Reports 

People with leg amputations, including those with diabetes, run the risk of overuse injuries like osteoarthritis, muscle atrophy or bone breaks in their intact limbs.   Now, new research is quantifying the impacts of amputations and diabetes, a leading cause of amputation, on those overuse ...